Affiliation:
1. Institute of Clinical Sciences, Maria Skłodowska-Curie Medical Academy, 00-136 Warsaw, Poland
2. Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, 04-730 Warsaw, Poland
Abstract
The liver, given its role as the central metabolic organ, is involved in many inherited metabolic disorders, including lysosomal storage diseases (LSDs). The aim of this manuscript was to provide a comprehensive overview on liver involvement in LSDs, focusing on clinical manifestation and its pathomechanisms. Gaucher disease, acid sphingomyelinase deficiency, and lysosomal acid lipase deficiency were thoroughly reviewed, with hepatic manifestation being a dominant clinical phenotype. The natural history of liver disease in the above-mentioned lysosomal disorders was delineated. The importance of Niemann–Pick type C disease as a cause of cholestatic jaundice, preceding neurological manifestation, was also highlighted. Diagnostic methods and current therapeutic management of LSDs were also discussed in the context of liver involvement.
Reference74 articles.
1. Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly;Mengel;Best Pract. Res. Clin. Gastroenterol.,2010
2. Szymańska, E., Lipiński, P., Rokicki, D., Książyk, J., and Tylki-Szymańska, A. (2020). Over 20-Year Follow-up of Patients with Hepatic Glycogen Storage Diseases: Single-Center Experience. Diagnostics, 10.
3. Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases;Ferreira;Mol. Genet. Metab.,2019
4. The cell biology of disease: Lysosomal storage disorders: The cellular impact of lysosomal dysfunction;Platt;J. Cell Biol.,2012
5. Lysosomal storage diseases;Platt;Nat. Rev. Dis. Primers,2018